Research establishes ERβ as a tumor suppressor in inflammatory breast cancer

FHS
July 4, 2023
3:07 am

A new editorial paper was published in Oncotarget’s Volume 14 on June 12, 2023, entitled, “ERβ as a mediator of estrogen signaling in inflammatory breast cancer.”

Cisplatin Shortage Eases; Air Pollution Linked to Breast Cancer; Pap Test Confusion

The nation’s supply of the widely used cancer drug cisplatin has almost returned to pre-shortage levels. (Becker’s Hospital Review) The FDA announced a new and

September 16, 2023

Higher heme iron intake linked to increased risk of type 2 diabetes

Higher intake of heme iron, the type found in red meat and other animal products-;as opposed to non-heme iron, found mostly in plant-based foods-;was associated

August 13, 2024

Research highlights link between sedentary behavior and increased mortality risk in older women

Based on decades-long observations of centenarians, author Dan Buettner (Blue Zones) conjectures that people live longer when they get up and move around after sitting

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.